238 related articles for article (PubMed ID: 17560055)
21. Preparation of azithromycin nanosuspensions by reactive precipitation method.
Hou CD; Wang JX; Le Y; Zou HK; Zhao H
Drug Dev Ind Pharm; 2012 Jul; 38(7):848-54. PubMed ID: 22092042
[TBL] [Abstract][Full Text] [Related]
22. Effective polymeric dispersants for vacuum, convection and freeze drying of drug nanosuspensions.
Kim S; Lee J
Int J Pharm; 2010 Sep; 397(1-2):218-24. PubMed ID: 20637852
[TBL] [Abstract][Full Text] [Related]
23. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process.
Won DH; Kim MS; Lee S; Park JS; Hwang SJ
Int J Pharm; 2005 Sep; 301(1-2):199-208. PubMed ID: 16024189
[TBL] [Abstract][Full Text] [Related]
24. Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam.
Ambrus R; Kocbek P; Kristl J; Sibanc R; Rajkó R; Szabó-Révész P
Int J Pharm; 2009 Nov; 381(2):153-9. PubMed ID: 19616609
[TBL] [Abstract][Full Text] [Related]
25. Nanosizing--oral formulation development and biopharmaceutical evaluation.
Kesisoglou F; Panmai S; Wu Y
Adv Drug Deliv Rev; 2007 Jul; 59(7):631-44. PubMed ID: 17601629
[TBL] [Abstract][Full Text] [Related]
26. A stable hydrocortisone nanosuspension for improved dissolution: Preparation, characterization and in vitro evaluation.
Ali HS; Khan S; York P; Shah SM; Khan J; Hussain Z; Khan BA
Pak J Pharm Sci; 2017 Sep; 30(5):1635-1643. PubMed ID: 29084684
[TBL] [Abstract][Full Text] [Related]
27. Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility.
Colombo M; Minussi C; Orthmann S; Staufenbiel S; Bodmeier R
Eur J Pharm Biopharm; 2018 Apr; 125():159-168. PubMed ID: 29371046
[TBL] [Abstract][Full Text] [Related]
28. Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology.
Liu G; Zhang D; Jiao Y; Zheng D; Liu Y; Duan C; Jia L; Zhang Q; Lou H
Int J Pharm; 2012 Jan; 422(1-2):516-22. PubMed ID: 22119965
[TBL] [Abstract][Full Text] [Related]
29. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticulation of poorly water soluble drugs using a wet-mill process and physicochemical properties of the nanopowders.
Tanaka Y; Inkyo M; Yumoto R; Nagai J; Takano M; Nagata S
Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1050-7. PubMed ID: 19801857
[TBL] [Abstract][Full Text] [Related]
31. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations.
Vogt M; Kunath K; Dressman JB
Eur J Pharm Biopharm; 2008 Feb; 68(2):283-8. PubMed ID: 17574403
[TBL] [Abstract][Full Text] [Related]
32. An Intensified Vibratory Milling Process for Enhancing the Breakage Kinetics during the Preparation of Drug Nanosuspensions.
Li M; Zhang L; Davé RN; Bilgili E
AAPS PharmSciTech; 2016 Apr; 17(2):389-99. PubMed ID: 26182907
[TBL] [Abstract][Full Text] [Related]
33. Performance comparison of two novel combinative particle-size-reduction technologies.
Salazar J; Müller RH; Möschwitzer JP
J Pharm Sci; 2013 May; 102(5):1636-49. PubMed ID: 23436640
[TBL] [Abstract][Full Text] [Related]
34. Preparation and evaluation of high dispersion stable nanocrystal formulation of poorly water-soluble compounds by using povacoat.
Yuminoki K; Seko F; Horii S; Takeuchi H; Teramoto K; Nakada Y; Hashimoto N
J Pharm Sci; 2014 Nov; 103(11):3772-3781. PubMed ID: 25209659
[TBL] [Abstract][Full Text] [Related]
35. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
Patel GV; Patel VB; Pathak A; Rajput SJ
Drug Dev Ind Pharm; 2014 Jan; 40(1):80-91. PubMed ID: 23323843
[TBL] [Abstract][Full Text] [Related]
36. Nanodispersions of taxifolin: impact of solid-state properties on dissolution behavior.
Shikov AN; Pozharitskaya ON; Miroshnyk I; Mirza S; Urakova IN; Hirsjärvi S; Makarov VG; Heinämäki J; Yliruusi J; Hiltunen R
Int J Pharm; 2009 Jul; 377(1-2):148-52. PubMed ID: 19426789
[TBL] [Abstract][Full Text] [Related]
37. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations.
Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R
Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923
[TBL] [Abstract][Full Text] [Related]
38. Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with Naproxen and Cinnarizine.
Kayaert P; Van den Mooter G
Eur J Pharm Biopharm; 2012 Aug; 81(3):650-6. PubMed ID: 22579733
[TBL] [Abstract][Full Text] [Related]
39. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
Hu J; Ng WK; Dong Y; Shen S; Tan RB
Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
[TBL] [Abstract][Full Text] [Related]
40. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
Widanapathirana L; Tale S; Reineke TM
Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
